Le Lézard
Classified in: Health, Business
Subjects: ERN, ACC

Salmon Evolution ASA: Results for the first quarter 2023


OSLO, Norway, May 23, 2023 /PRNewswire/ --

Highlights in the quarter            

Subsequent events           

The increase in biomass production continued in the first quarter with the Group having a net biomass production of around 740 tonnes and all-time high biomass production of around 320 tonnes in March alone. As per 31 March 2023 the Company had a total standing biomass of almost 1,500 tonnes.

Phase 1 of Indre Harøy was finalized in April 2023. With all the 12 tanks completed, this will allow for a streamlining of the production process with both production lines fully operational. The preparatory activities for phase 2 continued in the quarter. The Company has made no contractual commitments but is in advanced negotiations with contractors for phase 2 construction. The plan is to commence construction during the second half of 2023.

Work on the international expansion plans in South Korea through K Smart Farming and in North America continued in the quarter. 90 % design review for the smolt site in South Korea was completed as planned and work on the grow-out site has been intensified. In parallel, the permitting processes continued with important clarifications received with regards to key permits. In North America the Company continues to evaluate identified potential production sites as well as maintaining dialogue with various stakeholders, both public and private.

Summary and outlook

Since initiating operations at the Indre Harøy facility about 14 months ago, the Company has gradually ramped up production and a total of five batches have been stocked. Two smolt releases are scheduled for the second quarter, and three more are planned in the second half of 2023.

The increased mortality reported ultimo April was triggered by AGD, causing problems with gill health and is an important reminder of the biological aspect of the operation. Salmon farming is a complex operation and unexpected things can and will happen, stressing the importance of having a strong and capable organization. The event demonstrated the value of being located in the heart of the aquaculture cluster with solid access to competent people and suppliers and relevant infrastructure.

The Company has taken swift and appropriate actions to remedy the situation, including reduced temperatures and feeding, increased UV dosage on intake water, fast tracking harvest of batch 2 in a historically strong market and completed freshwater treatment of all remaining fish groups.

The freshwater treatment appears to have had a good effect, and the situation is now stabilizing with daily mortality back to normal levels post freshwater treatment. The Company has also recommenced feeding across the farm and is closely monitoring the situation.

Furthermore, the Company has implemented a number of actions to minimize the risk of such event happening in the future. This includes inter alia on-site freshwater production capabilities to be installed over the next couple of weeks, reducing response time to a minimum going forward and also enabling precautionary freshwater treatments, for example in connection with fish transfers.

-We are pleased to see that the decisive actions taken over the last weeks is now stabilizing the situation and enabling the Company to transition back to production modus, says CEO in Salmon Evolution Trond Håkon Schaug-Pettersen.

-The successfully completed freshwater treatment also gives invaluable operational experience that will enhance our capabilities to tackle challenges going forward, says Schaug-Pettersen.

Salmon Evolution continues to see a significant demand growth potential for salmon and the Company believes that land-based farming will need to play an important role alongside conventional farming for the industry to be able utilize the demand potential. With phase 1 at Indre Harøy now completed and having a strong financial platform, Salmon Evolution is in a unique position to continue to lead and shape the development of this industry.

Results presentation

CEO Trond Håkon Schaug-Pettersen and CFO Trond Vadset Veibust will present the results at Hotel Continental in Oslo, Tuesday 23 May at 08:00 a.m. CEST.

Participants may also follow the presentation and submit questions through a live webcast available on www.salmonevolution.no, or with the following link: https://events.webcast.no/viewer-registration/OGhLeEcM/register.

The presentation and subsequent Q&A will be held in English.

For further information, please contact:

Trond Håkon Schaug-Pettersen, CEO
[email protected]
+47 91 19 13 27

Trond Vadset Veibust, CFO
[email protected]
+47 48 09 05 95

The following files are available for download:

https://mb.cision.com/Public/19899/3772956/96a291a20708c606.pdf

SALME Q1 2023 report

https://mb.cision.com/Public/19899/3772956/a6e6c569e90b84d4.pdf

SALME Q1 2023 presentation


These press releases may also interest you

at 16:48
Enhancing opportunities for family connection and enrichment on vacation and beyond, the family-friendly Beaches Resorts joins global impact nonpro?t organization and longtime partner, Sesame Workshop, to debut all-new programming designed to get...

at 16:45
Endo, Inc. ("Endo" or the "Company"), a newly formed entity that recently acquired substantially all of the assets of Endo International plc ("EIP") as contemplated by EIP's plan of reorganization, will announce select first-quarter 2024 financial...

at 16:45
Always Best Care Senior Services, one of the leading senior care franchise systems in the United States, works with thousands of individuals and their families to provide personalized care plans that allow seniors to age in place at home. During...

at 16:30
Tivic Health® Systems, Inc. ("Tivic", Nasdaq: TIVC), a health tech company that develops and commercializes bioelectronic medicine, today announced its first quarter 2024 financial results with discussion of subsequent events. "Q1 2024 and the...

at 16:30
Weyerhaeuser Company and Firefighter Behavioral Health Alliance (FBHA) today announced the launch of Fighting Fires Together, a campaign designed to increase awareness around the importance of mental health support for wildland firefighters and...

at 16:15
enGene Holdings Inc. , a clinical-stage genetic medicines company whose non-viral lead program EG-70 is in a pivotal study for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC), today announced the election of Paul Hastings and Wouter...



News published on and distributed by: